Know Cancer

or
forgot password

Longitudinal Enumeration of Circulating Tumor Cells in Patients With Metastatic Colorectal Carcinomas


N/A
18 Years
N/A
Open (Enrolling)
Both
Colorectal Cancer, Neoplasm Metastasis

Thank you

Trial Information

Longitudinal Enumeration of Circulating Tumor Cells in Patients With Metastatic Colorectal Carcinomas


Inclusion Criteria:



- Measurable metastatic carcinoma of the colon or rectum.

- 1st or 2nd line chemotherapy (3rd line acceptable with epidermal growth factor
receptor [EGFR] targeted therapy)

- Chest/abdomen/pelvis scans every 6-12 weeks

- ECOG 0-2

- Hemoglobin (Hgb) > or = 8g/dl within 7 days prior to enrollment

- Age > or = to 18 years of age

Exclusion Criteria:

- Cumulative weekly blood draws exceeding 150mL/week

- Brain metastasis

- Prior history of other carcinoma within the last 5 years, except ductal carcinoma in
situ (DCIS), non-invasive cervical cancer or non-melanoma skin cancer

- Surgery within 14 days of the initial blood draw, excluding surgical placement of a
central venous device

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Principal Investigator

Steven Cohen, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Fox Chase Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

IMMC-06

NCT ID:

NCT00133913

Start Date:

March 2004

Completion Date:

January 2009

Related Keywords:

  • Colorectal Cancer
  • Neoplasm Metastasis
  • metastatic colorectal cancer
  • Neoplasms
  • Colorectal Neoplasms
  • Neoplastic Cells, Circulating
  • Neoplasm Metastasis

Name

Location

Fox Chase Cancer CenterPhiladelphia, Pennsylvania  19111